Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Recs

0
Player Avatar moof77 (53.55) Submitted: 11/11/2008 3:22:24 AM : Outperform Start Price: $20.37 VIVO Score: -55.03

Well managed company whose products will only see more demand in coming years.

Featured Broker Partners


Advertisement